IL-12-Independent costimulation pathways for interferon-gamma production in familial disseminated Mycobacterium avium complex infection

We have described previously a family with an apparent genetic susceptibility to disseminated Mycobacterium avium complex infection and an underlying defect in IL-12 regulation leading to abnormally low interferon-gamma production. Their T cells appear to act normally when in the presence of normal...

Ausführliche Beschreibung

Bibliographische Detailangaben
Veröffentlicht in:Clinical immunology (Orlando, Fla.). - 1999. - 91(1999), 2 vom: 09. Mai, Seite 234-41
1. Verfasser: Frucht, D M (VerfasserIn)
Weitere Verfasser: Sandberg, D I, Brown, M R, Gerstberger, S M, Holland, S M
Format: Aufsatz
Sprache:English
Veröffentlicht: 1999
Zugriff auf das übergeordnete Werk:Clinical immunology (Orlando, Fla.)
Schlagworte:Journal Article Antigens, CD B7-2 Antigen CD40 Antigens CD86 protein, human Membrane Glycoproteins CD40 Ligand 147205-72-9 Interleukin-12 187348-17-0 mehr... Interferon-gamma 82115-62-6
LEADER 01000naa a22002652 4500
001 NLM101604815
003 DE-627
005 20231222122617.0
007 tu
008 231222s1999 xx ||||| 00| ||eng c
028 5 2 |a pubmed24n0339.xml 
035 |a (DE-627)NLM101604815 
035 |a (NLM)10227816 
040 |a DE-627  |b ger  |c DE-627  |e rakwb 
041 |a eng 
100 1 |a Frucht, D M  |e verfasserin  |4 aut 
245 1 0 |a IL-12-Independent costimulation pathways for interferon-gamma production in familial disseminated Mycobacterium avium complex infection 
264 1 |c 1999 
336 |a Text  |b txt  |2 rdacontent 
337 |a ohne Hilfsmittel zu benutzen  |b n  |2 rdamedia 
338 |a Band  |b nc  |2 rdacarrier 
500 |a Date Completed 28.05.1999 
500 |a Date Revised 16.11.2017 
500 |a published: Print 
500 |a Citation Status MEDLINE 
520 |a We have described previously a family with an apparent genetic susceptibility to disseminated Mycobacterium avium complex infection and an underlying defect in IL-12 regulation leading to abnormally low interferon-gamma production. Their T cells appear to act normally when in the presence of normal accessory cells. Cell-to-cell contact was necessary for normal monocytes to complement the familial patient monocyte defect, suggesting the familial defect in interferon-gamma costimulation involves pathways requiring cell surface molecule interactions. In an effort to better characterize the abnormality in these patients, we examined the role of known costimulatory molecules in residual costimulation by patient PBMC compared to normals. Whereas normals utilized CD40/CD40L interactions and IL-12 production for optimal interferon-gamma costimulation in PHA-stimulated cocultures, familial patient interferon-gamma production was low and unaffected by their blockade. CD86 blockade caused a greater than 50% reduction in both normal and familial patient interferon-gamma production, implying that a majority of residual familial patient costimulation required this pathway. Furthermore, selected myelomonocytic cell lines (K562 and THP1) acted as potent accessory cells for interferon-gamma production by familial patient and normal T cells, largely independent of IL-12 production. However, CD86 blockade of K562 cell/familial cell cocultures resulted in less than a 20% reduction in interferon-gamma production, indicating that familial patient cells respond to IL-12- and CD86-independent costimulatory signals for interferon-gamma as well. Thus, we demonstrate that the familial defect also involves interferon-gamma costimulation pathways requiring both CD40/CD40L interaction and IL-12 production, while residual pathways remain that allow low-level interferon-gamma production. Familial Mycobacterium avium patient monocytes and certain myelomonocytic cell lines can be exploited to investigate IL-12-independent costimulation for interferon-gamma production 
650 4 |a Journal Article 
650 7 |a Antigens, CD  |2 NLM 
650 7 |a B7-2 Antigen  |2 NLM 
650 7 |a CD40 Antigens  |2 NLM 
650 7 |a CD86 protein, human  |2 NLM 
650 7 |a Membrane Glycoproteins  |2 NLM 
650 7 |a CD40 Ligand  |2 NLM 
650 7 |a 147205-72-9  |2 NLM 
650 7 |a Interleukin-12  |2 NLM 
650 7 |a 187348-17-0  |2 NLM 
650 7 |a Interferon-gamma  |2 NLM 
650 7 |a 82115-62-6  |2 NLM 
700 1 |a Sandberg, D I  |e verfasserin  |4 aut 
700 1 |a Brown, M R  |e verfasserin  |4 aut 
700 1 |a Gerstberger, S M  |e verfasserin  |4 aut 
700 1 |a Holland, S M  |e verfasserin  |4 aut 
773 0 8 |i Enthalten in  |t Clinical immunology (Orlando, Fla.)  |d 1999  |g 91(1999), 2 vom: 09. Mai, Seite 234-41  |w (DE-627)NLM098196855  |x 1521-7035  |7 nnns 
773 1 8 |g volume:91  |g year:1999  |g number:2  |g day:09  |g month:05  |g pages:234-41 
912 |a GBV_USEFLAG_A 
912 |a SYSFLAG_A 
912 |a GBV_NLM 
912 |a GBV_ILN_11 
912 |a GBV_ILN_24 
912 |a GBV_ILN_350 
951 |a AR 
952 |d 91  |j 1999  |e 2  |b 09  |c 05  |h 234-41